AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $405,318 | -0.5% | 5,035 | -1.4% | 0.00% | – |
| Q1 2024 | $407,459 | -1.7% | 5,106 | -2.0% | 0.00% | – |
| Q4 2023 | $414,505 | -68.7% | 5,208 | -72.5% | 0.00% | -100.0% |
| Q3 2023 | $1,323,297 | +390.0% | 18,934 | +403.8% | 0.00% | – |
| Q2 2023 | $270,050 | +13.9% | 3,758 | -2.2% | 0.00% | – |
| Q1 2023 | $237,098 | -16.0% | 3,844 | +5.1% | 0.00% | – |
| Q4 2022 | $282,219 | -5.9% | 3,659 | -17.6% | 0.00% | – |
| Q2 2021 | $300,000 | +16.3% | 4,441 | -2.6% | 0.00% | – |
| Q1 2021 | $258,000 | -55.4% | 4,558 | -35.8% | 0.00% | -100.0% |
| Q4 2020 | $578,000 | -6.8% | 7,099 | -18.4% | 0.00% | 0.0% |
| Q3 2020 | $620,000 | -3.0% | 8,697 | +11.9% | 0.00% | 0.0% |
| Q2 2020 | $639,000 | -51.5% | 7,769 | -65.3% | 0.00% | 0.0% |
| Q1 2020 | $1,318,000 | -6.9% | 22,420 | +63.8% | 0.00% | -50.0% |
| Q4 2019 | $1,415,000 | +673.2% | 13,687 | +51.7% | 0.00% | – |
| Q3 2019 | $183,000 | – | 9,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 991,754 | $58,345,000 | 37.79% |
| VR Adviser, LLC | 810,000 | $47,652,000 | 12.91% |
| ACUTA CAPITAL PARTNERS, LLC | 308,500 | $18,149,000 | 8.80% |
| Fairmount Funds Management LLC | 189,598 | $11,154,000 | 6.76% |
| RA Capital Management | 1,904,094 | $112,018,000 | 3.54% |
| Ghost Tree Capital, LLC | 215,000 | $12,648,000 | 3.36% |
| MORGAN JESS S & CO INC | 42,402 | $2,495,000 | 3.24% |
| RTW INVESTMENTS, LP | 1,052,969 | $61,946,000 | 2.67% |
| EAM Global Investors LLC | 50,649 | $2,980,000 | 1.74% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,172,014 | $68,950,000 | 1.67% |